InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.7600
+0.0300 (4.11%)
At close: Jun 15, 2026, 4:00 PM EDT
0.8285
+0.0685 (9.01%)
After-hours: Jun 15, 2026, 7:57 PM EDT
InspireMD Employees
InspireMD had 127 employees as of December 31, 2025. The number of employees increased by 41 or 47.67% compared to the previous year.
Employees
127
Change
41
Growth
47.67%
Revenue / Employee
$85,417
Profits / Employee
-$404,008
Market Cap
35.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 127 | 41 | 47.67% | 127 | 0 |
| Sep 30, 2025 | 66 | -14 | -17.50% | 66 | 0 |
| Jun 30, 2025 | 66 | -2 | -2.94% | 66 | 0 |
| Mar 31, 2025 | 66 | -2 | -2.94% | 66 | 0 |
| Dec 31, 2024 | 86 | 20 | 30.30% | 85 | 1 |
| Sep 30, 2024 | 80 | 14 | 21.21% | 80 | 0 |
| Jun 30, 2024 | 68 | - | - | 68 | 0 |
| Mar 31, 2024 | 68 | 12 | 21.43% | 68 | 0 |
| Dec 31, 2023 | 66 | 10 | 17.86% | 65 | 1 |
| Dec 31, 2022 | 56 | 4 | 7.69% | 55 | 1 |
| Dec 31, 2021 | 52 | 4 | 8.33% | 50 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Nortech Systems | 713 |
| TELA Bio | 218 |
| Baird Medical Investment Holdings | 146 |
| Cytosorbents | 129 |
| Sensus Healthcare | 60 |
| Modular Medical | 54 |
| PAVmed | 41 |
NSPR News
- 3 days ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures - GlobeNewsWire
- 7 days ago - InspireMD enrolls first patient in CGUARDIANS III study - TheFly
- 7 days ago - InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures - GlobeNewsWire
- 4 weeks ago - InspireMD Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - InspireMD price target lowered to $3 from $4 at Piper Sandler - TheFly
- 6 weeks ago - InspireMD reports Q1 EPS (16c), consensus (18c) - TheFly